 ?您的位置：對照品 > 標(biāo)準(zhǔn)品 > 分析標(biāo)準(zhǔn)品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：O006500 |
| 產(chǎn)品名稱：ODM-201 |
| 產(chǎn)品CAS：1297538-32-9 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
O006500 |
| 名稱: |
ODM-201 |
| 別名: |
N-[(1S)-2-[3-(3-Chloro-4-cyanophenyl)-1H-pyrazol-1-yl]-1-methylethyl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide; BAY 1841788; Darolutamide; |
| CAS號: |
1297538-32-9 |
| 分子式: |
C??H??ClN?O? |
| 分子量: |
398.85 |
| 類別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
ODM-201 is a compound being used as a novel next-generation androgen receptor-directed therapy for prostate cancer. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
